PMID,Sentence,Named-Entity,Label,Result
14578199,"N-methyl-D-aspartate receptor-induced toxicity has been shown to be calcium dependent; this study demonstrates that 2-amino-3-(4-butyl-3-hydroxyisoxazol-5-yl)propionic acid/kainate receptor-type neurotoxicity is also calcium-dependent, partly mediated by voltage sensitive calcium channels.",acid/kainate receptor-type neurotoxicity,CHEMICAL,1
14578199,"N-methyl-D-aspartate receptor-induced toxicity has been shown to be calcium dependent; this study demonstrates that 2-amino-3-(4-butyl-3-hydroxyisoxazol-5-yl)propionic acid/kainate receptor-type neurotoxicity is also calcium-dependent, partly mediated by voltage sensitive calcium channels.",voltage sensitive calcium channels,CHEMICAL,1
16389753,Enhanced intake of poly-unsaturated fatty acids may play an important role in the reversal of cancer related weight loss.,poly-unsaturated fatty acids,NUTRITION,1
16389753,Enhanced intake of poly-unsaturated fatty acids may play an important role in the reversal of cancer related weight loss.,related weight loss,DISEASE,1
16389753,Enhanced intake of poly-unsaturated fatty acids may play an important role in the reversal of cancer related weight loss.,poly-unsaturated fatty acids,CHEMICAL,1
15460168,"n-3 long chain polyunsaturated fatty acids (n-3 LC-PUFA), mainly eicosapentaenoic acid (EPA, 20:5 n-3) and docosahexaenoic acid (DHA, 22:6 n-3), are present in mammal tissues both from endogenous synthesis from desaturation and elongation of 18:3 n-3 and/or from dietary origin (marine products and fish oils).",n-3 long chain polyunsaturated fatty acids,NUTRITION,1
15460168,"n-3 long chain polyunsaturated fatty acids (n-3 LC-PUFA), mainly eicosapentaenoic acid (EPA, 20:5 n-3) and docosahexaenoic acid (DHA, 22:6 n-3), are present in mammal tissues both from endogenous synthesis from desaturation and elongation of 18:3 n-3 and/or from dietary origin (marine products and fish oils).",n-3,CHEMICAL,1
15460168,"n-3 long chain polyunsaturated fatty acids (n-3 LC-PUFA), mainly eicosapentaenoic acid (EPA, 20:5 n-3) and docosahexaenoic acid (DHA, 22:6 n-3), are present in mammal tissues both from endogenous synthesis from desaturation and elongation of 18:3 n-3 and/or from dietary origin (marine products and fish oils).",desaturation,DISEASE,1
15460168,"n-3 long chain polyunsaturated fatty acids (n-3 LC-PUFA), mainly eicosapentaenoic acid (EPA, 20:5 n-3) and docosahexaenoic acid (DHA, 22:6 n-3), are present in mammal tissues both from endogenous synthesis from desaturation and elongation of 18:3 n-3 and/or from dietary origin (marine products and fish oils).",n-3 long chain polyunsaturated fatty acids,CHEMICAL,1
15460168,"n-3 long chain polyunsaturated fatty acids (n-3 LC-PUFA), mainly eicosapentaenoic acid (EPA, 20:5 n-3) and docosahexaenoic acid (DHA, 22:6 n-3), are present in mammal tissues both from endogenous synthesis from desaturation and elongation of 18:3 n-3 and/or from dietary origin (marine products and fish oils).",eicosapentaenoic acid,CHEMICAL,1
15460168,"n-3 long chain polyunsaturated fatty acids (n-3 LC-PUFA), mainly eicosapentaenoic acid (EPA, 20:5 n-3) and docosahexaenoic acid (DHA, 22:6 n-3), are present in mammal tissues both from endogenous synthesis from desaturation and elongation of 18:3 n-3 and/or from dietary origin (marine products and fish oils).",n-3 LC-PUFA,CHEMICAL,1
32265706,"Meanwhile, the antianxiety mechanism of BAA was different with the antivisceral pain mechanism of BAA.",BAA,CHEMICAL,1
32265706,"Meanwhile, the antianxiety mechanism of BAA was different with the antivisceral pain mechanism of BAA.",antivisceral pain mechanism,DISEASE,1
26071110,IC87201 and ZL006 preferentially suppressed phase 2A pain behavior in the formalin test and suppressed allodynia induced by intraplantar complete Freund's adjuvant administration.,IC87201,CHEMICAL,1
26071110,IC87201 and ZL006 preferentially suppressed phase 2A pain behavior in the formalin test and suppressed allodynia induced by intraplantar complete Freund's adjuvant administration.,allodynia,DISEASE,1
26071110,IC87201 and ZL006 preferentially suppressed phase 2A pain behavior in the formalin test and suppressed allodynia induced by intraplantar complete Freund's adjuvant administration.,2A pain behavior,DISEASE,1
16871136,Female sexual arousal disorder is treated with estrogen replacement therapy when indicated or vaginal lubricants.,Female sexual arousal disorder,MENTAL_HEALTH,1
16871136,Female sexual arousal disorder is treated with estrogen replacement therapy when indicated or vaginal lubricants.,estrogen replacement therapy,CHEBI,1
16871136,Female sexual arousal disorder is treated with estrogen replacement therapy when indicated or vaginal lubricants.,vaginal lubricants,DISEASE,1
7806692,Gepirone is a novel antidepressant that holds promise for the treatment of atypical depression and that may be of heuristic value because of its relatively specific actions on the serotonergic system.,Gepirone,CHEMICAL,1
7806692,Gepirone is a novel antidepressant that holds promise for the treatment of atypical depression and that may be of heuristic value because of its relatively specific actions on the serotonergic system.,novel antidepressant,CHEMICAL,1
34442024,"Forty-three participants with CNCP and OUD were converted from a full mu-receptor agonist opioid (mean morphine equivalent dose: 328.3 mg) to BuNa, in an inpatient setting.",OUD,DISEASE,1
34442024,"Forty-three participants with CNCP and OUD were converted from a full mu-receptor agonist opioid (mean morphine equivalent dose: 328.3 mg) to BuNa, in an inpatient setting.",full mu-receptor agonist opioid,CHEBI,1
34442024,"Forty-three participants with CNCP and OUD were converted from a full mu-receptor agonist opioid (mean morphine equivalent dose: 328.3 mg) to BuNa, in an inpatient setting.",mean morphine equivalent dose,CHEMICAL,1
34442024,"Forty-three participants with CNCP and OUD were converted from a full mu-receptor agonist opioid (mean morphine equivalent dose: 328.3 mg) to BuNa, in an inpatient setting.",BuNa,CHEMICAL,1
2557712,"Muscimol (0.5-2 mg/kg, i.p.), a GABA-a receptor agonist, not only markedly potentiated clonidine (20 mg/kg i.p.)-induced aggressive behaviors but also elicited characteristic behaviors such as gnawing, reinforced irritability, and self-mutilation.",Muscimol,CHEMICAL,1
2557712,"Muscimol (0.5-2 mg/kg, i.p.), a GABA-a receptor agonist, not only markedly potentiated clonidine (20 mg/kg i.p.)-induced aggressive behaviors but also elicited characteristic behaviors such as gnawing, reinforced irritability, and self-mutilation.",irritability,DISEASE,1
2557712,"Muscimol (0.5-2 mg/kg, i.p.), a GABA-a receptor agonist, not only markedly potentiated clonidine (20 mg/kg i.p.)-induced aggressive behaviors but also elicited characteristic behaviors such as gnawing, reinforced irritability, and self-mutilation.",GABA-a receptor agonist,CHEBI,1
2557712,"Muscimol (0.5-2 mg/kg, i.p.), a GABA-a receptor agonist, not only markedly potentiated clonidine (20 mg/kg i.p.)-induced aggressive behaviors but also elicited characteristic behaviors such as gnawing, reinforced irritability, and self-mutilation.",clonidine,CHEMICAL,1
2557712,"Muscimol (0.5-2 mg/kg, i.p.), a GABA-a receptor agonist, not only markedly potentiated clonidine (20 mg/kg i.p.)-induced aggressive behaviors but also elicited characteristic behaviors such as gnawing, reinforced irritability, and self-mutilation.",i.p.)-induced aggressive behaviors,DISEASE,1
33667687,"Pitolisant was efficacious in reducing excessive daytime sleepiness and cataplexy compared with placebo, and it was well-tolerated in patients with severe narcolepsy symptoms as compared with modafinil.",Pitolisant,CHEMICAL,1
33667687,"Pitolisant was efficacious in reducing excessive daytime sleepiness and cataplexy compared with placebo, and it was well-tolerated in patients with severe narcolepsy symptoms as compared with modafinil.",cataplexy,MENTAL_HEALTH,1
33667687,"Pitolisant was efficacious in reducing excessive daytime sleepiness and cataplexy compared with placebo, and it was well-tolerated in patients with severe narcolepsy symptoms as compared with modafinil.",excessive daytime sleepiness,MENTAL_HEALTH,1
30755087,Non-medical use of benzodiazepines is rare among patients with anxiety disorders.,benzodiazepines,CHEMICAL,1
30755087,Non-medical use of benzodiazepines is rare among patients with anxiety disorders.,anxiety disorders,MENTAL_HEALTH,1
29438455,"Furthermore, the meta-analysis of prospective studies conducted in 4137 participants indicated that perinatal suboptimal vitamin D concentrations are significantly associated with a higher risk of ADHD in later life (RR: 1.40; 95% CI: 1.09, 1.81; I2 = 0.0%).",perinatal suboptimal vitamin D concentrations,CHEBI,1
29438455,"Furthermore, the meta-analysis of prospective studies conducted in 4137 participants indicated that perinatal suboptimal vitamin D concentrations are significantly associated with a higher risk of ADHD in later life (RR: 1.40; 95% CI: 1.09, 1.81; I2 = 0.0%).",ADHD,MENTAL_HEALTH,1
35025861,"However, due to the synergistic effect between diabetic pathology and neuroinflammation, and the prothrombotic profile in patients with diabetes, whether vitamin D is associated with risk of dementia among patients with diabetes is unclear.",vitamin D,CHEBI,1
35025861,"However, due to the synergistic effect between diabetic pathology and neuroinflammation, and the prothrombotic profile in patients with diabetes, whether vitamin D is associated with risk of dementia among patients with diabetes is unclear.",dementia,MENTAL_HEALTH,1
22750274,Haloperidol is the most widely used antipsychotic drug in the treatment of psychiatric disorders.,Haloperidol,CHEMICAL,1
22750274,Haloperidol is the most widely used antipsychotic drug in the treatment of psychiatric disorders.,psychiatric disorders,DISEASE,1
22750274,Haloperidol is the most widely used antipsychotic drug in the treatment of psychiatric disorders.,used antipsychotic drug,CHEBI,1
16734749,"Li+, used in the treatment of manic depression, stimulates volume-sensitive K+-Cl- COT of low K+ sheep red blood cells at cellular concentrations 3 mM, causes cell swelling, and appears to regulate K+-Cl- COT through a protein kinase C-dependent pathway.",Li+,CHEMICAL,1
16734749,"Li+, used in the treatment of manic depression, stimulates volume-sensitive K+-Cl- COT of low K+ sheep red blood cells at cellular concentrations 3 mM, causes cell swelling, and appears to regulate K+-Cl- COT through a protein kinase C-dependent pathway.",K+ sheep,CHEMICAL,1
16734749,"Li+, used in the treatment of manic depression, stimulates volume-sensitive K+-Cl- COT of low K+ sheep red blood cells at cellular concentrations 3 mM, causes cell swelling, and appears to regulate K+-Cl- COT through a protein kinase C-dependent pathway.",volume-sensitive K+-Cl- COT,CHEMICAL,1
34480721,"Although several retrospective studies have shown a lower incidence of T2DM with verapamil treatment, no prospective intervention studies have determined the efficacy of this drug in patients with T2DM.",T2DM,DISEASE,1
34480721,"Although several retrospective studies have shown a lower incidence of T2DM with verapamil treatment, no prospective intervention studies have determined the efficacy of this drug in patients with T2DM.",verapamil treatment,CHEMICAL,1
34480721,"Although several retrospective studies have shown a lower incidence of T2DM with verapamil treatment, no prospective intervention studies have determined the efficacy of this drug in patients with T2DM.",drug,CHEBI,1
33644980,Heavy alcohol drinking is associated with pancreatitis.,alcohol drinking,CHEMICAL,1
33644980,Heavy alcohol drinking is associated with pancreatitis.,pancreatitis,DISEASE,1
10064385,Vitamin E completely ameliorated neuronal loss following 400 and 800 mg/dl ethanol.,Vitamin E,CHEBI,1
10064385,Vitamin E completely ameliorated neuronal loss following 400 and 800 mg/dl ethanol.,neuronal loss,DISEASE,1
10064385,Vitamin E completely ameliorated neuronal loss following 400 and 800 mg/dl ethanol.,mg/dl ethanol,CHEMICAL,1
22519922,"Histamine H3 receptors reside on non-histamine neurons and regulate other neurotransmitters (e.g. acetylcholine, noradrenaline [norepinephrine]) suggesting that H3 antagonists have the potential to improve attention and impulsivity.",Histamine H3 receptors,CHEMICAL,1
22519922,"Histamine H3 receptors reside on non-histamine neurons and regulate other neurotransmitters (e.g. acetylcholine, noradrenaline [norepinephrine]) suggesting that H3 antagonists have the potential to improve attention and impulsivity.",non-histamine neurons,CHEMICAL,1
22519922,"Histamine H3 receptors reside on non-histamine neurons and regulate other neurotransmitters (e.g. acetylcholine, noradrenaline [norepinephrine]) suggesting that H3 antagonists have the potential to improve attention and impulsivity.",acetylcholine,CHEMICAL,1
22519922,"Histamine H3 receptors reside on non-histamine neurons and regulate other neurotransmitters (e.g. acetylcholine, noradrenaline [norepinephrine]) suggesting that H3 antagonists have the potential to improve attention and impulsivity.",norepinephrine,CHEMICAL,1
22519922,"Histamine H3 receptors reside on non-histamine neurons and regulate other neurotransmitters (e.g. acetylcholine, noradrenaline [norepinephrine]) suggesting that H3 antagonists have the potential to improve attention and impulsivity.",noradrenaline,CHEMICAL,1
32883138,"Antimanic treatments are unlikely to help symptoms of depression but an exception to this rule would be a genuine mood stabiliser, such as lithium.",Antimanic treatments,DISEASE,1
32883138,"Antimanic treatments are unlikely to help symptoms of depression but an exception to this rule would be a genuine mood stabiliser, such as lithium.",genuine mood stabiliser,CHEBI,1
32883138,"Antimanic treatments are unlikely to help symptoms of depression but an exception to this rule would be a genuine mood stabiliser, such as lithium.",lithium,NUTRITION,1
32883138,"Antimanic treatments are unlikely to help symptoms of depression but an exception to this rule would be a genuine mood stabiliser, such as lithium.",depression,MENTAL_HEALTH,1
32381378,"Some psychological effects of THC may be acute (altered time and space perception, sensory disability, decreased vigilance, mood and dissociative disorders, hallucinations and delirium, impaired learning and memory, impaired cognitive and motor performance, panic attacks and anxiety) or chronic (lack of motivation, disorganisation of thoughts, increase in frequency and severity of schizophrenic crises).",THC,CHEMICAL,1
32381378,"Some psychological effects of THC may be acute (altered time and space perception, sensory disability, decreased vigilance, mood and dissociative disorders, hallucinations and delirium, impaired learning and memory, impaired cognitive and motor performance, panic attacks and anxiety) or chronic (lack of motivation, disorganisation of thoughts, increase in frequency and severity of schizophrenic crises).",schizophrenic crises,DISEASE,1
32381378,"Some psychological effects of THC may be acute (altered time and space perception, sensory disability, decreased vigilance, mood and dissociative disorders, hallucinations and delirium, impaired learning and memory, impaired cognitive and motor performance, panic attacks and anxiety) or chronic (lack of motivation, disorganisation of thoughts, increase in frequency and severity of schizophrenic crises).",dissociative,DISEASE,1
34562138,"A lymph node exam was documented in 14 of the 63 patients (22%), and statistical analysis showed that among all variables (age, gender, tumor size, tumor stages, tobacco or alcohol use, or history of skin cancer), only the size of the tumor correlated positively with a lymph node examination (RRE 1.15 [95% CI 1.06-1.25], p < 0.001).",tumor,DISEASE,1
34562138,"A lymph node exam was documented in 14 of the 63 patients (22%), and statistical analysis showed that among all variables (age, gender, tumor size, tumor stages, tobacco or alcohol use, or history of skin cancer), only the size of the tumor correlated positively with a lymph node examination (RRE 1.15 [95% CI 1.06-1.25], p < 0.001).",alcohol,CHEMICAL,1
34562138,"A lymph node exam was documented in 14 of the 63 patients (22%), and statistical analysis showed that among all variables (age, gender, tumor size, tumor stages, tobacco or alcohol use, or history of skin cancer), only the size of the tumor correlated positively with a lymph node examination (RRE 1.15 [95% CI 1.06-1.25], p < 0.001).",skin cancer,DISEASE,1
34562138,"A lymph node exam was documented in 14 of the 63 patients (22%), and statistical analysis showed that among all variables (age, gender, tumor size, tumor stages, tobacco or alcohol use, or history of skin cancer), only the size of the tumor correlated positively with a lymph node examination (RRE 1.15 [95% CI 1.06-1.25], p < 0.001).",tumor size,DISEASE,1
34562138,"A lymph node exam was documented in 14 of the 63 patients (22%), and statistical analysis showed that among all variables (age, gender, tumor size, tumor stages, tobacco or alcohol use, or history of skin cancer), only the size of the tumor correlated positively with a lymph node examination (RRE 1.15 [95% CI 1.06-1.25], p < 0.001).",tumor stages,DISEASE,1
15198914,"It is possible that the most sensitive manifestation of pesticide neurotoxicity is a general malaise lacking in specificity and related to mild cognitive dysfunction, similar to that described for Gulf War syndrome.",pesticide neurotoxicity,CHEMICAL,1
15198914,"It is possible that the most sensitive manifestation of pesticide neurotoxicity is a general malaise lacking in specificity and related to mild cognitive dysfunction, similar to that described for Gulf War syndrome.",mild cognitive dysfunction,DISEASE,1
27445967,"The opposite interplay between peroxisome proliferator-activated receptor gamma (PPAR gamma) and Wnt/beta-catenin signaling has led to the categorization of neurodegenerative diseases (NDs) as either NDs in which PPAR gamma is downregulated while the canonical Wnt/beta-catenin pathway is upregulated [amyotrophic lateral sclerosis (ALS), Parkinson's disease, Huntington's disease, multiple sclerosis, Friedreich's ataxia] or NDs in which PPAR gamma is upregulated while the canonical Wnt/beta-catenin signaling is downregulated (bipolar disorder, schizophrenia, Alzheimer's disease).",PPAR gamma,CHEBI,1
27445967,"The opposite interplay between peroxisome proliferator-activated receptor gamma (PPAR gamma) and Wnt/beta-catenin signaling has led to the categorization of neurodegenerative diseases (NDs) as either NDs in which PPAR gamma is downregulated while the canonical Wnt/beta-catenin pathway is upregulated [amyotrophic lateral sclerosis (ALS), Parkinson's disease, Huntington's disease, multiple sclerosis, Friedreich's ataxia] or NDs in which PPAR gamma is upregulated while the canonical Wnt/beta-catenin signaling is downregulated (bipolar disorder, schizophrenia, Alzheimer's disease).",neurodegenerative diseases,DISEASE,1
15733814,"Eplerenone and spironolactone increase natriuresis and cause renal retention of potassium when plasma aldosterone is high, i.e., both agents are facultative diuretics.",Eplerenone,CHEMICAL,1
15733814,"Eplerenone and spironolactone increase natriuresis and cause renal retention of potassium when plasma aldosterone is high, i.e., both agents are facultative diuretics.",potassium,CHEMICAL,1
15733814,"Eplerenone and spironolactone increase natriuresis and cause renal retention of potassium when plasma aldosterone is high, i.e., both agents are facultative diuretics.",renal retention,DISEASE,1
15733814,"Eplerenone and spironolactone increase natriuresis and cause renal retention of potassium when plasma aldosterone is high, i.e., both agents are facultative diuretics.",spironolactone,CHEMICAL,1
27221098,"On admission, gliclazide was initiated due to her hyperglycaemia, which we attributed to maturity onset diabetes of the young.",gliclazide,CHEMICAL,1
27221098,"On admission, gliclazide was initiated due to her hyperglycaemia, which we attributed to maturity onset diabetes of the young.",hyperglycaemia,DISEASE,1
30716372,"The human antimicrobial and immunomodulatory peptide LL-37 is ubiquitously expressed and secreted by epithelial cells of mucosal surfaces including the gastrointestinal tract, the primary absorption site of orally administered drugs and food components.",human antimicrobial peptide,CHEBI,1
30716372,"The human antimicrobial and immunomodulatory peptide LL-37 is ubiquitously expressed and secreted by epithelial cells of mucosal surfaces including the gastrointestinal tract, the primary absorption site of orally administered drugs and food components.",gastrointestinal tract,DISEASE,1
34082137,"Interventions with normalization of the endocrine perturbations are followed by clear improvements of the multiple abnormalities in both clinical, experimental, cellular and molecular studies, suggesting that the pathogenesis of abdominal preponderance of body fat and its endocrine, anthropometric and metabolic abnormalities are indeed consequences of the endocrine abnormalities identified.",its's endocrine abnormalities,CHEBI,1
34082137,"Interventions with normalization of the endocrine perturbations are followed by clear improvements of the multiple abnormalities in both clinical, experimental, cellular and molecular studies, suggesting that the pathogenesis of abdominal preponderance of body fat and its endocrine, anthropometric and metabolic abnormalities are indeed consequences of the endocrine abnormalities identified.",endocrine abnormalities,CHEBI,1
34082137,"Interventions with normalization of the endocrine perturbations are followed by clear improvements of the multiple abnormalities in both clinical, experimental, cellular and molecular studies, suggesting that the pathogenesis of abdominal preponderance of body fat and its endocrine, anthropometric and metabolic abnormalities are indeed consequences of the endocrine abnormalities identified.",endocrine perturbations,CHEBI,1
34082137,"Interventions with normalization of the endocrine perturbations are followed by clear improvements of the multiple abnormalities in both clinical, experimental, cellular and molecular studies, suggesting that the pathogenesis of abdominal preponderance of body fat and its endocrine, anthropometric and metabolic abnormalities are indeed consequences of the endocrine abnormalities identified.",multiple abnormalities,DISEASE,1
30655633,"For the treatment of Chlamydial prostatitis macrolides were shown to be more effective than fluoroquinolones, whereas no differences were observed in microbiological and clinical efficacy between macrolides and tetracyclines for the treatment of infections caused by intracellular pathogens.",macrolides,CHEMICAL,1
30655633,"For the treatment of Chlamydial prostatitis macrolides were shown to be more effective than fluoroquinolones, whereas no differences were observed in microbiological and clinical efficacy between macrolides and tetracyclines for the treatment of infections caused by intracellular pathogens.",tetracyclines,CHEMICAL,1
33551122,More complex genetic variations in drug response are important in alcoholism and possibly other forms of substance abuse.,drug response,CHEBI,1
33551122,More complex genetic variations in drug response are important in alcoholism and possibly other forms of substance abuse.,substance abuse,MENTAL_HEALTH,1
33551122,More complex genetic variations in drug response are important in alcoholism and possibly other forms of substance abuse.,alcoholism,DISEASE,1
23227932,Hyperammonemia completely modifies the effects of pregnanolone and pregnenolone.,Hyperammonemia,DISEASE,1
23227932,Hyperammonemia completely modifies the effects of pregnanolone and pregnenolone.,pregnenolone,CHEMICAL,1
23227932,Hyperammonemia completely modifies the effects of pregnanolone and pregnenolone.,pregnanolone,CHEMICAL,1
21585220,Quinolones are a class of antibacterial agents for the treatment of several infectious diseases (e.g. urinary and respiratory tract infections).,Quinolones,CHEMICAL,1
21585220,Quinolones are a class of antibacterial agents for the treatment of several infectious diseases (e.g. urinary and respiratory tract infections).,several infectious diseases,DISEASE,1
21585220,Quinolones are a class of antibacterial agents for the treatment of several infectious diseases (e.g. urinary and respiratory tract infections).,urinary tract infections,DISEASE,1
21585220,Quinolones are a class of antibacterial agents for the treatment of several infectious diseases (e.g. urinary and respiratory tract infections).,antibacterial agents,CHEBI,1
34794025,"Fenamidone negatively affected development of zebrafish embryos, causing a delay of hatching time at concentrations of 2.5 and 5 μM. Fenamidone caused morphological deformities in zebrafish, including pericardial edema, yolk sac edema, tail deformities, and spinal curvature.",Fenamidone,CHEMICAL,1
34794025,"Fenamidone negatively affected development of zebrafish embryos, causing a delay of hatching time at concentrations of 2.5 and 5 μM. Fenamidone caused morphological deformities in zebrafish, including pericardial edema, yolk sac edema, tail deformities, and spinal curvature.",yolk sac edema,DISEASE,1
34794025,"Fenamidone negatively affected development of zebrafish embryos, causing a delay of hatching time at concentrations of 2.5 and 5 μM. Fenamidone caused morphological deformities in zebrafish, including pericardial edema, yolk sac edema, tail deformities, and spinal curvature.",pericardial edema,DISEASE,1
34794025,"Fenamidone negatively affected development of zebrafish embryos, causing a delay of hatching time at concentrations of 2.5 and 5 μM. Fenamidone caused morphological deformities in zebrafish, including pericardial edema, yolk sac edema, tail deformities, and spinal curvature.",spinal curvature,DISEASE,1
34794025,"Fenamidone negatively affected development of zebrafish embryos, causing a delay of hatching time at concentrations of 2.5 and 5 μM. Fenamidone caused morphological deformities in zebrafish, including pericardial edema, yolk sac edema, tail deformities, and spinal curvature.",μM. Fenamidone,CHEMICAL,1
34153313,"The kappa opioid receptor agonist U50,488H produces a dose-dependent relief of this mechanical hypersensitivity, regardless of the cycle phase.","agonist U50,488H",CHEMICAL,1
34153313,"The kappa opioid receptor agonist U50,488H produces a dose-dependent relief of this mechanical hypersensitivity, regardless of the cycle phase.",mechanical hypersensitivity,DISEASE,1
34153313,"The kappa opioid receptor agonist U50,488H produces a dose-dependent relief of this mechanical hypersensitivity, regardless of the cycle phase.","agonist U50,488H",CHEBI,1
17372808,"In patients with an elevated ammonia level, altered mental status, and liver disease, who do not have a clear inciting event for liver disease decompensation, overwhelming evidence of hepatic decompensation, or who do not respond to appropriate therapy for hepatic encephalopathy, hypothyroidism should be considered and evaluated.",hypothyroidism,DISEASE,1
17372808,"In patients with an elevated ammonia level, altered mental status, and liver disease, who do not have a clear inciting event for liver disease decompensation, overwhelming evidence of hepatic decompensation, or who do not respond to appropriate therapy for hepatic encephalopathy, hypothyroidism should be considered and evaluated.",hepatic encephalopathy,DISEASE,1
17372808,"In patients with an elevated ammonia level, altered mental status, and liver disease, who do not have a clear inciting event for liver disease decompensation, overwhelming evidence of hepatic decompensation, or who do not respond to appropriate therapy for hepatic encephalopathy, hypothyroidism should be considered and evaluated.",liver disease,DISEASE,1
17372808,"In patients with an elevated ammonia level, altered mental status, and liver disease, who do not have a clear inciting event for liver disease decompensation, overwhelming evidence of hepatic decompensation, or who do not respond to appropriate therapy for hepatic encephalopathy, hypothyroidism should be considered and evaluated.",hepatic decompensation,DISEASE,1
17372808,"In patients with an elevated ammonia level, altered mental status, and liver disease, who do not have a clear inciting event for liver disease decompensation, overwhelming evidence of hepatic decompensation, or who do not respond to appropriate therapy for hepatic encephalopathy, hypothyroidism should be considered and evaluated.",elevated ammonia level,CHEMICAL,1
32051627,Clozapine is an antipsychotic drug which is used in the treatment of therapy-resistant schizophrenia.,Clozapine,CHEMICAL,1
32051627,Clozapine is an antipsychotic drug which is used in the treatment of therapy-resistant schizophrenia.,antipsychotic drug,CHEBI,1
26491593,Palmitoylethanolamide could be an effective treatment for autism syndrome.,Palmitoylethanolamide,CHEMICAL,1
26491593,Palmitoylethanolamide could be an effective treatment for autism syndrome.,autism syndrome,MENTAL_HEALTH,1
25122509,Alcohol withdrawal is clearly associated with severe anxiety symptoms.,Alcohol withdrawal,CHEMICAL,1
25122509,Alcohol withdrawal is clearly associated with severe anxiety symptoms.,severe anxiety symptoms,MENTAL_HEALTH,1
34072024,"Fatty acids, such as palmitoleic acid (0.14%), palmitic acid (21.42%), linoleic acid (11.02%), oleic acid (59.97%), and stearic acid (7.44%), were identified as constituents of SBHX, producing significant anxiolytic-like effects and preventing body-weight gain in mice receiving the hypercaloric diet without altering their water or food consumption.",stearic acid,CHEMICAL,1
34072024,"Fatty acids, such as palmitoleic acid (0.14%), palmitic acid (21.42%), linoleic acid (11.02%), oleic acid (59.97%), and stearic acid (7.44%), were identified as constituents of SBHX, producing significant anxiolytic-like effects and preventing body-weight gain in mice receiving the hypercaloric diet without altering their water or food consumption.",body-weight gain,DISEASE,1
34072024,"Fatty acids, such as palmitoleic acid (0.14%), palmitic acid (21.42%), linoleic acid (11.02%), oleic acid (59.97%), and stearic acid (7.44%), were identified as constituents of SBHX, producing significant anxiolytic-like effects and preventing body-weight gain in mice receiving the hypercaloric diet without altering their water or food consumption.",Fatty acids,NUTRITION,1
34072024,"Fatty acids, such as palmitoleic acid (0.14%), palmitic acid (21.42%), linoleic acid (11.02%), oleic acid (59.97%), and stearic acid (7.44%), were identified as constituents of SBHX, producing significant anxiolytic-like effects and preventing body-weight gain in mice receiving the hypercaloric diet without altering their water or food consumption.",palmitoleic acid,CHEMICAL,1
34072024,"Fatty acids, such as palmitoleic acid (0.14%), palmitic acid (21.42%), linoleic acid (11.02%), oleic acid (59.97%), and stearic acid (7.44%), were identified as constituents of SBHX, producing significant anxiolytic-like effects and preventing body-weight gain in mice receiving the hypercaloric diet without altering their water or food consumption.",oleic acid,CHEMICAL,1
34072024,"Fatty acids, such as palmitoleic acid (0.14%), palmitic acid (21.42%), linoleic acid (11.02%), oleic acid (59.97%), and stearic acid (7.44%), were identified as constituents of SBHX, producing significant anxiolytic-like effects and preventing body-weight gain in mice receiving the hypercaloric diet without altering their water or food consumption.",linoleic acid,CHEMICAL,1
34072024,"Fatty acids, such as palmitoleic acid (0.14%), palmitic acid (21.42%), linoleic acid (11.02%), oleic acid (59.97%), and stearic acid (7.44%), were identified as constituents of SBHX, producing significant anxiolytic-like effects and preventing body-weight gain in mice receiving the hypercaloric diet without altering their water or food consumption.",palmitic acid,CHEMICAL,1
31624248,"In addition, chronic stress increased the expression of VEGF, MMP-2, MMP-7 and MMP-9 in transplanted tumour tissue, and catecholamine hormones enhanced the expression of metastasis-related proteins.",chronic stress,MENTAL_HEALTH,1
31624248,"In addition, chronic stress increased the expression of VEGF, MMP-2, MMP-7 and MMP-9 in transplanted tumour tissue, and catecholamine hormones enhanced the expression of metastasis-related proteins.",tumour tissue,DISEASE,1
21886573,"Chronic use of METH causes psychiatric symptoms, such as hallucinations and delusions, and long-term cognitive deficits, which are indistinguishable from paranoid schizophrenia.",METH,CHEMICAL,1
21886573,"Chronic use of METH causes psychiatric symptoms, such as hallucinations and delusions, and long-term cognitive deficits, which are indistinguishable from paranoid schizophrenia.",psychiatric symptoms,DISEASE,1
21886573,"Chronic use of METH causes psychiatric symptoms, such as hallucinations and delusions, and long-term cognitive deficits, which are indistinguishable from paranoid schizophrenia.",delusions,MENTAL_HEALTH,1
21886573,"Chronic use of METH causes psychiatric symptoms, such as hallucinations and delusions, and long-term cognitive deficits, which are indistinguishable from paranoid schizophrenia.",hallucinations,MENTAL_HEALTH,1
21886573,"Chronic use of METH causes psychiatric symptoms, such as hallucinations and delusions, and long-term cognitive deficits, which are indistinguishable from paranoid schizophrenia.",long-term cognitive deficits,DISEASE,1
28237807,"Carboplatin, another cancer chemotherapeutic drug that is often used in combination with paclitaxel, sensitized mice to the nociceptive effects of paclitaxel.",cancer chemotherapeutic drug,CHEBI,1
28237807,"Carboplatin, another cancer chemotherapeutic drug that is often used in combination with paclitaxel, sensitized mice to the nociceptive effects of paclitaxel.",paclitaxel,CHEMICAL,1
28237807,"Carboplatin, another cancer chemotherapeutic drug that is often used in combination with paclitaxel, sensitized mice to the nociceptive effects of paclitaxel.",cancer chemotherapeutic drug,DISEASE,1
28237807,"Carboplatin, another cancer chemotherapeutic drug that is often used in combination with paclitaxel, sensitized mice to the nociceptive effects of paclitaxel.",Carboplatin,CHEMICAL,1
22134476,"High levels of impulsivity are a core symptom of psychiatric disorders such as ADHD, mania, personality disorders and drug addiction.",impulsivity,DISEASE,1
22134476,"High levels of impulsivity are a core symptom of psychiatric disorders such as ADHD, mania, personality disorders and drug addiction.",ADHD,MENTAL_HEALTH,1
22134476,"High levels of impulsivity are a core symptom of psychiatric disorders such as ADHD, mania, personality disorders and drug addiction.",drug addiction,CHEBI,1
22134476,"High levels of impulsivity are a core symptom of psychiatric disorders such as ADHD, mania, personality disorders and drug addiction.",mania,MENTAL_HEALTH,1
22134476,"High levels of impulsivity are a core symptom of psychiatric disorders such as ADHD, mania, personality disorders and drug addiction.",personality disorders,MENTAL_HEALTH,1
22134476,"High levels of impulsivity are a core symptom of psychiatric disorders such as ADHD, mania, personality disorders and drug addiction.",psychiatric disorders,DISEASE,1
22832356,These findings may have therapeutic implications for the clinical use of HDAC inhibitors in psychiatric disorders.,HDAC inhibitors,CHEMICAL,1
22832356,These findings may have therapeutic implications for the clinical use of HDAC inhibitors in psychiatric disorders.,psychiatric disorders,DISEASE,1
24036059,"The chronic administration of high doses of dexamethasone (DEX), a synthetic glucocorticoid receptor agonist, impairs long-term memory and motor coordination, reduces body weight and induces mortality in mice.",dexamethasone,CHEMICAL,1
24036059,"The chronic administration of high doses of dexamethasone (DEX), a synthetic glucocorticoid receptor agonist, impairs long-term memory and motor coordination, reduces body weight and induces mortality in mice.",memory motor coordination,DISEASE,1
33739701,"Class I, III, or bepridil as class IV excepting lidocaine and mexiletine are used to prevent paroxysmal atrial fibrillation.",bepridil,CHEMICAL,1
33739701,"Class I, III, or bepridil as class IV excepting lidocaine and mexiletine are used to prevent paroxysmal atrial fibrillation.",paroxysmal atrial fibrillation,DISEASE,1
32886223,Maternal Vitamin B12 deficiency during pregnancy is associated with offspring neuropsychiatric disorders.,Maternal Vitamin B12 deficiency,CHEBI,1
32886223,Maternal Vitamin B12 deficiency during pregnancy is associated with offspring neuropsychiatric disorders.,offspring neuropsychiatric disorders,DISEASE,1
34213723,"MP, a dopamine reuptake inhibitor, helps manage attention-deficit hyperactivity disorder (ADHD) and is abused as a cognitive enhancer; it has a reduced addiction liability.",dopamine reuptake inhibitor,CHEBI,1
34213723,"MP, a dopamine reuptake inhibitor, helps manage attention-deficit hyperactivity disorder (ADHD) and is abused as a cognitive enhancer; it has a reduced addiction liability.",ADHD,MENTAL_HEALTH,1
34213723,"MP, a dopamine reuptake inhibitor, helps manage attention-deficit hyperactivity disorder (ADHD) and is abused as a cognitive enhancer; it has a reduced addiction liability.",attention-deficit hyperactivity disorder,MENTAL_HEALTH,1
34213723,"MP, a dopamine reuptake inhibitor, helps manage attention-deficit hyperactivity disorder (ADHD) and is abused as a cognitive enhancer; it has a reduced addiction liability.",MP,DISEASE,1
33914772,"Compared to healthy children, patients during periods of thyroid hormone elevation (74.29%) and normalized thyroid hormones (31.43%) had higher frequencies of behavioral abnormalities and scorings of total CBCL scale (P = 0.01; P = 0.04, respectively) and its subscales' [Anxious/Depressed (P = 0.02; P = 0.04), Withdrawn/Depressed (P = 0.03; P = 0.04) and Somatic Complaints (P = 0.03; P = 0.127) and Social (P = 0.01; P = 0.225), Thought (P = 0.01; P = 0.128) and Attention (P = 0.01; P = 0.01) problems], indicating internalizing and externalizing problems.",normalized thyroid hormones,CHEBI,1
33914772,"Compared to healthy children, patients during periods of thyroid hormone elevation (74.29%) and normalized thyroid hormones (31.43%) had higher frequencies of behavioral abnormalities and scorings of total CBCL scale (P = 0.01; P = 0.04, respectively) and its subscales' [Anxious/Depressed (P = 0.02; P = 0.04), Withdrawn/Depressed (P = 0.03; P = 0.04) and Somatic Complaints (P = 0.03; P = 0.127) and Social (P = 0.01; P = 0.225), Thought (P = 0.01; P = 0.128) and Attention (P = 0.01; P = 0.01) problems], indicating internalizing and externalizing problems.",behavioral abnormalities,DISEASE,1
15729086,"Betahistine, a histamine enhancer with H1 agonistic/H3 antagonistic properties (48 mg t.i.d.), was coadministered with olanzapine (10 mg/day) in three first-episode schizophrenia patients for 6 weeks.",Betahistine,CHEMICAL,1
15729086,"Betahistine, a histamine enhancer with H1 agonistic/H3 antagonistic properties (48 mg t.i.d.), was coadministered with olanzapine (10 mg/day) in three first-episode schizophrenia patients for 6 weeks.",olanzapine,CHEMICAL,1
15729086,"Betahistine, a histamine enhancer with H1 agonistic/H3 antagonistic properties (48 mg t.i.d.), was coadministered with olanzapine (10 mg/day) in three first-episode schizophrenia patients for 6 weeks.",first-episode schizophrenia patients,MENTAL_HEALTH,1
15729086,"Betahistine, a histamine enhancer with H1 agonistic/H3 antagonistic properties (48 mg t.i.d.), was coadministered with olanzapine (10 mg/day) in three first-episode schizophrenia patients for 6 weeks.",histamine enhancer,CHEMICAL,1
15729086,"Betahistine, a histamine enhancer with H1 agonistic/H3 antagonistic properties (48 mg t.i.d.), was coadministered with olanzapine (10 mg/day) in three first-episode schizophrenia patients for 6 weeks.",t.i.d,CHEMICAL,1
34453973,"Altogether, our results suggest that increased glutamate, GluN2B activation, and likely calcium increase indicative of glutamate excitotoxicity-induced neuronal loss in LHb possibly endorse the emergence of ethanol withdrawal symptoms, while their inhibition might help in alleviating the ethanol withdrawal symptoms.",excitotoxicity-induced neuronal loss,DISEASE,1
34453973,"Altogether, our results suggest that increased glutamate, GluN2B activation, and likely calcium increase indicative of glutamate excitotoxicity-induced neuronal loss in LHb possibly endorse the emergence of ethanol withdrawal symptoms, while their inhibition might help in alleviating the ethanol withdrawal symptoms.",ethanol withdrawal symptoms,CHEMICAL,1
34453973,"Altogether, our results suggest that increased glutamate, GluN2B activation, and likely calcium increase indicative of glutamate excitotoxicity-induced neuronal loss in LHb possibly endorse the emergence of ethanol withdrawal symptoms, while their inhibition might help in alleviating the ethanol withdrawal symptoms.",increased glutamate indicative,CHEMICAL,1
34453973,"Altogether, our results suggest that increased glutamate, GluN2B activation, and likely calcium increase indicative of glutamate excitotoxicity-induced neuronal loss in LHb possibly endorse the emergence of ethanol withdrawal symptoms, while their inhibition might help in alleviating the ethanol withdrawal symptoms.",calcium increase,CHEMICAL,1
34453973,"Altogether, our results suggest that increased glutamate, GluN2B activation, and likely calcium increase indicative of glutamate excitotoxicity-induced neuronal loss in LHb possibly endorse the emergence of ethanol withdrawal symptoms, while their inhibition might help in alleviating the ethanol withdrawal symptoms.",GluN2B activation,DISEASE,1
19828388,"As compared to cirrhotic HCC, this kind of tumour has some peculiarities, such as: (a) a lower male preponderance and a bimodal age distribution; (b) a lower prevalence of the three main risk factors (hepatitis B and C virus infections and alcohol abuse), with an increased prevalence of other etiologic factors, such as exposure to genotoxic substances and sex hormones, inherited diseases, genetic mutations; (c) a more advanced tumour stage at the time of diagnosis, as it is usually detected due to the occurrence of cancer-related symptoms, outside any scheduled surveillance program; (d) a much higher amenability to hepatic resection, due to the low risk of liver failure even after extended parenchymal mutilation; (e) overall and disease-free survivals after resection of non-advanced tumours (meeting the Milano criteria) comparable to that obtained with liver transplantation in cirrhotic patients carrying an early tumour; (f) overall survival strictly dependent on tumour burden (and its recurrence) and barely influenced by liver function.",tumour,DISEASE,1
19828388,"As compared to cirrhotic HCC, this kind of tumour has some peculiarities, such as: (a) a lower male preponderance and a bimodal age distribution; (b) a lower prevalence of the three main risk factors (hepatitis B and C virus infections and alcohol abuse), with an increased prevalence of other etiologic factors, such as exposure to genotoxic substances and sex hormones, inherited diseases, genetic mutations; (c) a more advanced tumour stage at the time of diagnosis, as it is usually detected due to the occurrence of cancer-related symptoms, outside any scheduled surveillance program; (d) a much higher amenability to hepatic resection, due to the low risk of liver failure even after extended parenchymal mutilation; (e) overall and disease-free survivals after resection of non-advanced tumours (meeting the Milano criteria) comparable to that obtained with liver transplantation in cirrhotic patients carrying an early tumour; (f) overall survival strictly dependent on tumour burden (and its recurrence) and barely influenced by liver function.",tumour burden,DISEASE,1
19828388,"As compared to cirrhotic HCC, this kind of tumour has some peculiarities, such as: (a) a lower male preponderance and a bimodal age distribution; (b) a lower prevalence of the three main risk factors (hepatitis B and C virus infections and alcohol abuse), with an increased prevalence of other etiologic factors, such as exposure to genotoxic substances and sex hormones, inherited diseases, genetic mutations; (c) a more advanced tumour stage at the time of diagnosis, as it is usually detected due to the occurrence of cancer-related symptoms, outside any scheduled surveillance program; (d) a much higher amenability to hepatic resection, due to the low risk of liver failure even after extended parenchymal mutilation; (e) overall and disease-free survivals after resection of non-advanced tumours (meeting the Milano criteria) comparable to that obtained with liver transplantation in cirrhotic patients carrying an early tumour; (f) overall survival strictly dependent on tumour burden (and its recurrence) and barely influenced by liver function.",non-advanced tumours,DISEASE,1
19828388,"As compared to cirrhotic HCC, this kind of tumour has some peculiarities, such as: (a) a lower male preponderance and a bimodal age distribution; (b) a lower prevalence of the three main risk factors (hepatitis B and C virus infections and alcohol abuse), with an increased prevalence of other etiologic factors, such as exposure to genotoxic substances and sex hormones, inherited diseases, genetic mutations; (c) a more advanced tumour stage at the time of diagnosis, as it is usually detected due to the occurrence of cancer-related symptoms, outside any scheduled surveillance program; (d) a much higher amenability to hepatic resection, due to the low risk of liver failure even after extended parenchymal mutilation; (e) overall and disease-free survivals after resection of non-advanced tumours (meeting the Milano criteria) comparable to that obtained with liver transplantation in cirrhotic patients carrying an early tumour; (f) overall survival strictly dependent on tumour burden (and its recurrence) and barely influenced by liver function.",liver failure,DISEASE,1
19828388,"As compared to cirrhotic HCC, this kind of tumour has some peculiarities, such as: (a) a lower male preponderance and a bimodal age distribution; (b) a lower prevalence of the three main risk factors (hepatitis B and C virus infections and alcohol abuse), with an increased prevalence of other etiologic factors, such as exposure to genotoxic substances and sex hormones, inherited diseases, genetic mutations; (c) a more advanced tumour stage at the time of diagnosis, as it is usually detected due to the occurrence of cancer-related symptoms, outside any scheduled surveillance program; (d) a much higher amenability to hepatic resection, due to the low risk of liver failure even after extended parenchymal mutilation; (e) overall and disease-free survivals after resection of non-advanced tumours (meeting the Milano criteria) comparable to that obtained with liver transplantation in cirrhotic patients carrying an early tumour; (f) overall survival strictly dependent on tumour burden (and its recurrence) and barely influenced by liver function.",cirrhotic HCC,DISEASE,1
7521326,"The addition of dopamine antagonists to the regimens of SUI-resistant patients appears to be a useful approach for OCD patients with a comorbid chronic tic disorder (e.g., Tourette's syndrome) and possibly for those with concurrent psychotic spectrum disorders.",dopamine antagonists,CHEBI,1
7521326,"The addition of dopamine antagonists to the regimens of SUI-resistant patients appears to be a useful approach for OCD patients with a comorbid chronic tic disorder (e.g., Tourette's syndrome) and possibly for those with concurrent psychotic spectrum disorders.",comorbid chronic tic disorder,MENTAL_HEALTH,1
7521326,"The addition of dopamine antagonists to the regimens of SUI-resistant patients appears to be a useful approach for OCD patients with a comorbid chronic tic disorder (e.g., Tourette's syndrome) and possibly for those with concurrent psychotic spectrum disorders.",concurrent psychotic spectrum disorders,DISEASE,1
7521326,"The addition of dopamine antagonists to the regimens of SUI-resistant patients appears to be a useful approach for OCD patients with a comorbid chronic tic disorder (e.g., Tourette's syndrome) and possibly for those with concurrent psychotic spectrum disorders.",Tourette's syndrome,DISEASE,1
7521326,"The addition of dopamine antagonists to the regimens of SUI-resistant patients appears to be a useful approach for OCD patients with a comorbid chronic tic disorder (e.g., Tourette's syndrome) and possibly for those with concurrent psychotic spectrum disorders.",SUI-resistant patients,DISEASE,1
7521326,"The addition of dopamine antagonists to the regimens of SUI-resistant patients appears to be a useful approach for OCD patients with a comorbid chronic tic disorder (e.g., Tourette's syndrome) and possibly for those with concurrent psychotic spectrum disorders.",dopamine antagonists,CHEMICAL,1
7521326,"The addition of dopamine antagonists to the regimens of SUI-resistant patients appears to be a useful approach for OCD patients with a comorbid chronic tic disorder (e.g., Tourette's syndrome) and possibly for those with concurrent psychotic spectrum disorders.",OCD patients,DISEASE,1
8217063,"However, lithium is a highly specific treatment for bipolar disorder.",lithium,NUTRITION,1
8217063,"However, lithium is a highly specific treatment for bipolar disorder.",bipolar disorder,MENTAL_HEALTH,1
31128204,"The prenatal administration of VPA has induced social impairment, repetitive behavior, hyperlocomotion, anxiety and low exploratory activity in rats.",VPA,CHEMICAL,1
31128204,"The prenatal administration of VPA has induced social impairment, repetitive behavior, hyperlocomotion, anxiety and low exploratory activity in rats.",anxiety,MENTAL_HEALTH,1
31128204,"The prenatal administration of VPA has induced social impairment, repetitive behavior, hyperlocomotion, anxiety and low exploratory activity in rats.",repetitive behavior,DISEASE,1
2840978,"Baseline cortisol was significantly elevated in depressed as compared with panic patients, but not with controls.",Baseline cortisol,CHEMICAL,1
2840978,"Baseline cortisol was significantly elevated in depressed as compared with panic patients, but not with controls.",panic patients,DISEASE,1
35066169,Our findings showed that the allergic rhinitis induced by OVA challenge in sensitized rats induces anxiety-like behavior.,allergic rhinitis,DISEASE,1
35066169,Our findings showed that the allergic rhinitis induced by OVA challenge in sensitized rats induces anxiety-like behavior.,anxiety-like behavior,DISEASE,1
26781550,"Rather, the evidence leads us to conclude that both early use and heavy use of cannabis are more likely in individuals with a vulnerability to psychosis.",cannabis,CHEMICAL,1
26781550,"Rather, the evidence leads us to conclude that both early use and heavy use of cannabis are more likely in individuals with a vulnerability to psychosis.",psychosis,MENTAL_HEALTH,1
30292070,"Individuals with gambling disorder (GD) report much higher rates of post-traumatic stress symptoms and post-traumatic stress disorder (PTSS/D) than the general population, and individuals with both PTSS/D and GD often report much greater distress and impairment in daily life in comparison to individuals with GD alone (Grubbs, Chapman, Milner, Gutierrez, & Bradley, 2018).",gambling disorder,DISEASE,1
30292070,"Individuals with gambling disorder (GD) report much higher rates of post-traumatic stress symptoms and post-traumatic stress disorder (PTSS/D) than the general population, and individuals with both PTSS/D and GD often report much greater distress and impairment in daily life in comparison to individuals with GD alone (Grubbs, Chapman, Milner, Gutierrez, & Bradley, 2018).",post-traumatic stress symptoms,DISEASE,1
30292070,"Individuals with gambling disorder (GD) report much higher rates of post-traumatic stress symptoms and post-traumatic stress disorder (PTSS/D) than the general population, and individuals with both PTSS/D and GD often report much greater distress and impairment in daily life in comparison to individuals with GD alone (Grubbs, Chapman, Milner, Gutierrez, & Bradley, 2018).",post-traumatic stress disorder,MENTAL_HEALTH,1
30292070,"Individuals with gambling disorder (GD) report much higher rates of post-traumatic stress symptoms and post-traumatic stress disorder (PTSS/D) than the general population, and individuals with both PTSS/D and GD often report much greater distress and impairment in daily life in comparison to individuals with GD alone (Grubbs, Chapman, Milner, Gutierrez, & Bradley, 2018).",GD,CHEMICAL,1
30292070,"Individuals with gambling disorder (GD) report much higher rates of post-traumatic stress symptoms and post-traumatic stress disorder (PTSS/D) than the general population, and individuals with both PTSS/D and GD often report much greater distress and impairment in daily life in comparison to individuals with GD alone (Grubbs, Chapman, Milner, Gutierrez, & Bradley, 2018).",GD Grubbs,CHEMICAL,1
25227974,Opioid analgesics are used commonly in end-stage cancer patients for pain treatment.,Opioid analgesics,CHEBI,1
25227974,Opioid analgesics are used commonly in end-stage cancer patients for pain treatment.,pain treatment,DISEASE,1
25227974,Opioid analgesics are used commonly in end-stage cancer patients for pain treatment.,end-stage cancer patients,DISEASE,1
31962287,SE animals were injected with the inverse CB1 receptor agonist AM251.,SE animals,DISEASE,1
31962287,SE animals were injected with the inverse CB1 receptor agonist AM251.,agonist AM251,CHEMICAL,1
31962287,SE animals were injected with the inverse CB1 receptor agonist AM251.,agonist AM251,CHEBI,1
11470967,"Unfortunately, typical antipsychotic agents such as haloperidol, which selectively antagonizes dopamine D-2 receptors, can induce extrapyramidal syndromes such as tardive parkinsonism.",haloperidol,CHEMICAL,1
11470967,"Unfortunately, typical antipsychotic agents such as haloperidol, which selectively antagonizes dopamine D-2 receptors, can induce extrapyramidal syndromes such as tardive parkinsonism.",tardive parkinsonism,DISEASE,1
11470967,"Unfortunately, typical antipsychotic agents such as haloperidol, which selectively antagonizes dopamine D-2 receptors, can induce extrapyramidal syndromes such as tardive parkinsonism.",extrapyramidal syndromes,MENTAL_HEALTH,1
31269538,"Ten adult patients with severe pain from redback spider envenoming were administered 15 mg intravenous ketamine after standard analgesia, then up to 4 oral doses of ketamine 25- 50 mg.",spider envenoming,DISEASE,1
31269538,"Ten adult patients with severe pain from redback spider envenoming were administered 15 mg intravenous ketamine after standard analgesia, then up to 4 oral doses of ketamine 25- 50 mg.",ketamine    mg,CHEMICAL,1
31269538,"Ten adult patients with severe pain from redback spider envenoming were administered 15 mg intravenous ketamine after standard analgesia, then up to 4 oral doses of ketamine 25- 50 mg.",mg intravenous ketamine,CHEMICAL,1
31269538,"Ten adult patients with severe pain from redback spider envenoming were administered 15 mg intravenous ketamine after standard analgesia, then up to 4 oral doses of ketamine 25- 50 mg.",standard analgesia,MENTAL_HEALTH,1
31269538,"Ten adult patients with severe pain from redback spider envenoming were administered 15 mg intravenous ketamine after standard analgesia, then up to 4 oral doses of ketamine 25- 50 mg.",severe pain,DISEASE,1
9673858,The use of clozapine and other novel antipsychotic agents is also likely to represent an important step in the prevention and treatment of tardive dystonia.,clozapine,CHEMICAL,1
9673858,The use of clozapine and other novel antipsychotic agents is also likely to represent an important step in the prevention and treatment of tardive dystonia.,tardive dystonia,DISEASE,1
31526831,"Cholecystokinin (CCK), through the CCK-2 receptor, exerts complex effects on anxiety.",Cholecystokinin,CHEMICAL,1
31526831,"Cholecystokinin (CCK), through the CCK-2 receptor, exerts complex effects on anxiety.",anxiety,MENTAL_HEALTH,1
34177891,"Overall, clinical and preclinical evidences strongly suggest that the GABAB receptor is a therapeutic candidate for depression and anxiety disorders.",GABAB receptor,CHEMICAL,1
34177891,"Overall, clinical and preclinical evidences strongly suggest that the GABAB receptor is a therapeutic candidate for depression and anxiety disorders.",depression,MENTAL_HEALTH,1
34177891,"Overall, clinical and preclinical evidences strongly suggest that the GABAB receptor is a therapeutic candidate for depression and anxiety disorders.",anxiety disorders,MENTAL_HEALTH,1
8072794,"The antioxidants alpha-tocopherol and sodium selenite, the nootropic agent piracetam, and the amino acid L-tryptophan prevent amnesia.",acid L-tryptophan,CHEMICAL,1
8072794,"The antioxidants alpha-tocopherol and sodium selenite, the nootropic agent piracetam, and the amino acid L-tryptophan prevent amnesia.",amnesia,MENTAL_HEALTH,1
8072794,"The antioxidants alpha-tocopherol and sodium selenite, the nootropic agent piracetam, and the amino acid L-tryptophan prevent amnesia.",nootropic agent piracetam,CHEMICAL,1
8072794,"The antioxidants alpha-tocopherol and sodium selenite, the nootropic agent piracetam, and the amino acid L-tryptophan prevent amnesia.",sodium selenite,CHEMICAL,1
8072794,"The antioxidants alpha-tocopherol and sodium selenite, the nootropic agent piracetam, and the amino acid L-tryptophan prevent amnesia.",antioxidants alpha-tocopherol,NUTRITION,1
23680468,We aimed to examine the association between MDA and A-ADHD.,MDA,CHEMICAL,1
23680468,We aimed to examine the association between MDA and A-ADHD.,A-ADHD,DISEASE,1
32654402,The outcome with pegylated IFN (PEG-IFN) and newer NUCs may be even better because of more effective treatment and/or a low risk of resistance.,PEG-IFN,CHEMICAL,1
32654402,The outcome with pegylated IFN (PEG-IFN) and newer NUCs may be even better because of more effective treatment and/or a low risk of resistance.,resistance,MENTAL_HEALTH,1
32654402,The outcome with pegylated IFN (PEG-IFN) and newer NUCs may be even better because of more effective treatment and/or a low risk of resistance.,newer NUCs,CHEMICAL,1
32654402,The outcome with pegylated IFN (PEG-IFN) and newer NUCs may be even better because of more effective treatment and/or a low risk of resistance.,pegylated IFN,CHEMICAL,1
27417982,Adrenergic agents and vasodilators are associated with a high prevalence of orthostatic hypotension in diabetic patients.,Adrenergic agents,CHEBI,1
27417982,Adrenergic agents and vasodilators are associated with a high prevalence of orthostatic hypotension in diabetic patients.,diabetic patients,DISEASE,1
27417982,Adrenergic agents and vasodilators are associated with a high prevalence of orthostatic hypotension in diabetic patients.,orthostatic hypotension,DISEASE,1
31108875,The anticonvulsant drugs valproic acid and valpromide inhibit EBV in Burkitt lymphoma cells.,drugs valproic acid,CHEMICAL,1
31108875,The anticonvulsant drugs valproic acid and valpromide inhibit EBV in Burkitt lymphoma cells.,Burkitt lymphoma cells,DISEASE,1
19490092,"In this study, we investigated the molecular mechanisms by which the non-selective cannabinoid receptor agonist WIN55,212-2 (WIN) protects mouse nigrostriatal neurons from 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity and neuroinflammation.","non-selective cannabinoid receptor agonist WIN55,212",CHEMICAL,1
19490092,"In this study, we investigated the molecular mechanisms by which the non-selective cannabinoid receptor agonist WIN55,212-2 (WIN) protects mouse nigrostriatal neurons from 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity and neuroinflammation.",(MPTP)-induced neurotoxicity,DISEASE,1
19490092,"In this study, we investigated the molecular mechanisms by which the non-selective cannabinoid receptor agonist WIN55,212-2 (WIN) protects mouse nigrostriatal neurons from 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity and neuroinflammation.",neuroinflammation,DISEASE,1
19490092,"In this study, we investigated the molecular mechanisms by which the non-selective cannabinoid receptor agonist WIN55,212-2 (WIN) protects mouse nigrostriatal neurons from 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity and neuroinflammation.","non-selective cannabinoid receptor agonist WIN55,212",CHEBI,1
32937186,"Taken together, the present results showed that morphine administration could improve stress-induced memory impairment and anxiety in the rats exposed to the inescapable acute stress.",morphine administration,CHEMICAL,1
32937186,"Taken together, the present results showed that morphine administration could improve stress-induced memory impairment and anxiety in the rats exposed to the inescapable acute stress.",anxiety,MENTAL_HEALTH,1
32937186,"Taken together, the present results showed that morphine administration could improve stress-induced memory impairment and anxiety in the rats exposed to the inescapable acute stress.",stress-induced memory impairment,DISEASE,1
23436669,"Anxiety disorders can occur in intoxication by stimulants, as well as in withdrawal syndrome, both by stimulants and sedatives.",Anxiety disorders,MENTAL_HEALTH,1
23436669,"Anxiety disorders can occur in intoxication by stimulants, as well as in withdrawal syndrome, both by stimulants and sedatives.",stimulants,CHEMICAL,1
23436669,"Anxiety disorders can occur in intoxication by stimulants, as well as in withdrawal syndrome, both by stimulants and sedatives.",withdrawal syndrome,DISEASE,1
15179444,"TC-1734 was very well tolerated in acute and chronic oral toxicity studies in mice, rats and dogs.",TC-1734,CHEMICAL,1
15179444,"TC-1734 was very well tolerated in acute and chronic oral toxicity studies in mice, rats and dogs.",acute oral toxicity studies,DISEASE,1
35093492,Plasma HPA axis hormones were assayed by ELISA and enteroid and colorectal cancer cell line cultures were used to verify function.,Plasma HPA axis hormones,CHEBI,1
35093492,Plasma HPA axis hormones were assayed by ELISA and enteroid and colorectal cancer cell line cultures were used to verify function.,cancer cell line cultures,DISEASE,1
9583357,"A human protein, C-peptide, thought to be a useless byproduct of insulin may protect against devastating heart and nerve damage that diabetes causes.",C-peptide,CHEMICAL,1
9583357,"A human protein, C-peptide, thought to be a useless byproduct of insulin may protect against devastating heart and nerve damage that diabetes causes.",devastating heart damage,DISEASE,1
31918180,"However, potential effects of ADT treatment on neurocognitive dysfunction remain unclear.",ADT treatment,CHEMICAL,1
31918180,"However, potential effects of ADT treatment on neurocognitive dysfunction remain unclear.",neurocognitive dysfunction,DISEASE,1
1376106,"Serious suicidal behavior, affective disorders, and a variety of other psychopathologic behaviors and syndromes have been found to correlate with measures of the serotonin system.",suicidal behavior,MENTAL_HEALTH,1
1376106,"Serious suicidal behavior, affective disorders, and a variety of other psychopathologic behaviors and syndromes have been found to correlate with measures of the serotonin system.",serotonin system,CHEMICAL,1
1376106,"Serious suicidal behavior, affective disorders, and a variety of other psychopathologic behaviors and syndromes have been found to correlate with measures of the serotonin system.",affective disorders,MENTAL_HEALTH,1
21648337,"The aims of this case-control study were to test whether cholesterol levels in male suicidal patients (N=20) with borderline personality disorder (BPD) are lower than in male non-suicidal patients (N=20) with BPD and male healthy control group (N=20), and to evaluate the influence of structured individual psychoanalytic psychotherapy on suicidal behavior.",borderline personality disorder,MENTAL_HEALTH,1
21648337,"The aims of this case-control study were to test whether cholesterol levels in male suicidal patients (N=20) with borderline personality disorder (BPD) are lower than in male non-suicidal patients (N=20) with BPD and male healthy control group (N=20), and to evaluate the influence of structured individual psychoanalytic psychotherapy on suicidal behavior.",BPD,DISEASE,1
21648337,"The aims of this case-control study were to test whether cholesterol levels in male suicidal patients (N=20) with borderline personality disorder (BPD) are lower than in male non-suicidal patients (N=20) with BPD and male healthy control group (N=20), and to evaluate the influence of structured individual psychoanalytic psychotherapy on suicidal behavior.",male non-suicidal patients,DISEASE,1
21648337,"The aims of this case-control study were to test whether cholesterol levels in male suicidal patients (N=20) with borderline personality disorder (BPD) are lower than in male non-suicidal patients (N=20) with BPD and male healthy control group (N=20), and to evaluate the influence of structured individual psychoanalytic psychotherapy on suicidal behavior.",cholesterol levels,NUTRITION,1
21648337,"The aims of this case-control study were to test whether cholesterol levels in male suicidal patients (N=20) with borderline personality disorder (BPD) are lower than in male non-suicidal patients (N=20) with BPD and male healthy control group (N=20), and to evaluate the influence of structured individual psychoanalytic psychotherapy on suicidal behavior.",suicidal behavior,MENTAL_HEALTH,1
15655528,"Where known, the mode of action in cardiovascular disease is from antagonism of endogenous catecholamine responses in the heart (mainly at beta1-adrenoceptors), while the worrisome side effects of bronchospasm result from airway beta2-adrenoceptor blockade.",bronchospasm,DISEASE,1
15655528,"Where known, the mode of action in cardiovascular disease is from antagonism of endogenous catecholamine responses in the heart (mainly at beta1-adrenoceptors), while the worrisome side effects of bronchospasm result from airway beta2-adrenoceptor blockade.",airway beta2-adrenoceptor blockade,DISEASE,1
15655528,"Where known, the mode of action in cardiovascular disease is from antagonism of endogenous catecholamine responses in the heart (mainly at beta1-adrenoceptors), while the worrisome side effects of bronchospasm result from airway beta2-adrenoceptor blockade.",cardiovascular disease,DISEASE,1
15655528,"Where known, the mode of action in cardiovascular disease is from antagonism of endogenous catecholamine responses in the heart (mainly at beta1-adrenoceptors), while the worrisome side effects of bronchospasm result from airway beta2-adrenoceptor blockade.",endogenous catecholamine responses,CHEMICAL,1
7871108,"Six months after the disclosure of the test results, both gene carriers and noncarriers reported a significant decrease in unwanted intrusive thoughts about HD.",gene carriers,CHEBI,1
7871108,"Six months after the disclosure of the test results, both gene carriers and noncarriers reported a significant decrease in unwanted intrusive thoughts about HD.",unwanted intrusive thoughts,MENTAL_HEALTH,1
8861189,Zinc supplementation or cisapride could be a therapeutic option in addition to psychological and other approaches in anorexia nervosa.,cisapride,CHEMICAL,1
8861189,Zinc supplementation or cisapride could be a therapeutic option in addition to psychological and other approaches in anorexia nervosa.,anorexia nervosa,MENTAL_HEALTH,1
8861189,Zinc supplementation or cisapride could be a therapeutic option in addition to psychological and other approaches in anorexia nervosa.,Zinc supplementation,CHEMICAL,1
34606437,"Solriamfetol, a dopamine/norepinephrine reuptake inhibitor, is approved in the United States and European Union for excessive daytime sleepiness in adults with narcolepsy (75-150 mg/day) or obstructive sleep apnea (OSA; 37.5-150 mg/day).",dopamine/norepinephrine reuptake inhibitor,CHEMICAL,1
34606437,"Solriamfetol, a dopamine/norepinephrine reuptake inhibitor, is approved in the United States and European Union for excessive daytime sleepiness in adults with narcolepsy (75-150 mg/day) or obstructive sleep apnea (OSA; 37.5-150 mg/day).",obstructive sleep apnea,MENTAL_HEALTH,1
34606437,"Solriamfetol, a dopamine/norepinephrine reuptake inhibitor, is approved in the United States and European Union for excessive daytime sleepiness in adults with narcolepsy (75-150 mg/day) or obstructive sleep apnea (OSA; 37.5-150 mg/day).",OSA,DISEASE,1
34606437,"Solriamfetol, a dopamine/norepinephrine reuptake inhibitor, is approved in the United States and European Union for excessive daytime sleepiness in adults with narcolepsy (75-150 mg/day) or obstructive sleep apnea (OSA; 37.5-150 mg/day).",narcolepsy,MENTAL_HEALTH,1
34606437,"Solriamfetol, a dopamine/norepinephrine reuptake inhibitor, is approved in the United States and European Union for excessive daytime sleepiness in adults with narcolepsy (75-150 mg/day) or obstructive sleep apnea (OSA; 37.5-150 mg/day).",excessive daytime sleepiness,MENTAL_HEALTH,1
34606437,"Solriamfetol, a dopamine/norepinephrine reuptake inhibitor, is approved in the United States and European Union for excessive daytime sleepiness in adults with narcolepsy (75-150 mg/day) or obstructive sleep apnea (OSA; 37.5-150 mg/day).",Solriamfetol,CHEMICAL,1
19010975,"Results demonstrate that inhibition of 5-HT and noradrenaline reuptake by duloxetine markedly reduces food intake, suggesting that this may be a novel approach for the treatment of obesity.",duloxetine,CHEMICAL,1
19010975,"Results demonstrate that inhibition of 5-HT and noradrenaline reuptake by duloxetine markedly reduces food intake, suggesting that this may be a novel approach for the treatment of obesity.",5-HT reuptake,CHEMICAL,1
19010975,"Results demonstrate that inhibition of 5-HT and noradrenaline reuptake by duloxetine markedly reduces food intake, suggesting that this may be a novel approach for the treatment of obesity.",noradrenaline,CHEMICAL,1
34720995,"After adjustment for all covariates, higher UA had a dose-response association with a lower risk of MCI (all P for  trend Conclusions: High blood UA level is associated with reduced risks of MCI among Chinese older adults, highlighting the potential of managing UA in daily life for maintaining late-life cognition.",High blood UA level,CHEMICAL,1
34720995,"After adjustment for all covariates, higher UA had a dose-response association with a lower risk of MCI (all P for  trend Conclusions: High blood UA level is associated with reduced risks of MCI among Chinese older adults, highlighting the potential of managing UA in daily life for maintaining late-life cognition.",MCI,DISEASE,1
25843346,"The results showed that (1) occluding the left carotid artery of Mongolian gerbils not only decreased the cortex specific gravity (cortex edema) but also increased AVP levels in the ipsilateral cortex (ischemic area) including left prefrontal lobe, left parietal lobe, left temporal lobe, left occipital lobe and left hippocampus for the first 6 hours, and did not change of the cortex specific gravity and AVP concentration in the right cortex (non-ischemic area); (2) there were many negative relationships between the specific gravity and AVP levels in the ischemic cortex; (3) intranasal AVP (50 ng or 200 ng), which could pass through the blood-brain barrier to the brain, aggravated the focal cortex edema, whereas intranasal AVP receptor antagonist-D(CH2)5Tyr(ET)DAVP (2 µg) mitigated the cortex edema in the ischemic area after occluding the left carotid artery of Mongolian gerbils; and (4) either intranasal AVP or AVP receptor antagonist did not evoke that edema in the non-ischemic cortex.",intranasal AVP receptor antagonist-D(CH2)5Tyr(ET)DAVP,CHEMICAL,1
25843346,"The results showed that (1) occluding the left carotid artery of Mongolian gerbils not only decreased the cortex specific gravity (cortex edema) but also increased AVP levels in the ipsilateral cortex (ischemic area) including left prefrontal lobe, left parietal lobe, left temporal lobe, left occipital lobe and left hippocampus for the first 6 hours, and did not change of the cortex specific gravity and AVP concentration in the right cortex (non-ischemic area); (2) there were many negative relationships between the specific gravity and AVP levels in the ischemic cortex; (3) intranasal AVP (50 ng or 200 ng), which could pass through the blood-brain barrier to the brain, aggravated the focal cortex edema, whereas intranasal AVP receptor antagonist-D(CH2)5Tyr(ET)DAVP (2 µg) mitigated the cortex edema in the ischemic area after occluding the left carotid artery of Mongolian gerbils; and (4) either intranasal AVP or AVP receptor antagonist did not evoke that edema in the non-ischemic cortex.",cortex edema,DISEASE,1
25843346,"The results showed that (1) occluding the left carotid artery of Mongolian gerbils not only decreased the cortex specific gravity (cortex edema) but also increased AVP levels in the ipsilateral cortex (ischemic area) including left prefrontal lobe, left parietal lobe, left temporal lobe, left occipital lobe and left hippocampus for the first 6 hours, and did not change of the cortex specific gravity and AVP concentration in the right cortex (non-ischemic area); (2) there were many negative relationships between the specific gravity and AVP levels in the ischemic cortex; (3) intranasal AVP (50 ng or 200 ng), which could pass through the blood-brain barrier to the brain, aggravated the focal cortex edema, whereas intranasal AVP receptor antagonist-D(CH2)5Tyr(ET)DAVP (2 µg) mitigated the cortex edema in the ischemic area after occluding the left carotid artery of Mongolian gerbils; and (4) either intranasal AVP or AVP receptor antagonist did not evoke that edema in the non-ischemic cortex.",AVP levels,CHEMICAL,1
25843346,"The results showed that (1) occluding the left carotid artery of Mongolian gerbils not only decreased the cortex specific gravity (cortex edema) but also increased AVP levels in the ipsilateral cortex (ischemic area) including left prefrontal lobe, left parietal lobe, left temporal lobe, left occipital lobe and left hippocampus for the first 6 hours, and did not change of the cortex specific gravity and AVP concentration in the right cortex (non-ischemic area); (2) there were many negative relationships between the specific gravity and AVP levels in the ischemic cortex; (3) intranasal AVP (50 ng or 200 ng), which could pass through the blood-brain barrier to the brain, aggravated the focal cortex edema, whereas intranasal AVP receptor antagonist-D(CH2)5Tyr(ET)DAVP (2 µg) mitigated the cortex edema in the ischemic area after occluding the left carotid artery of Mongolian gerbils; and (4) either intranasal AVP or AVP receptor antagonist did not evoke that edema in the non-ischemic cortex.",focal cortex edema,DISEASE,1
25843346,"The results showed that (1) occluding the left carotid artery of Mongolian gerbils not only decreased the cortex specific gravity (cortex edema) but also increased AVP levels in the ipsilateral cortex (ischemic area) including left prefrontal lobe, left parietal lobe, left temporal lobe, left occipital lobe and left hippocampus for the first 6 hours, and did not change of the cortex specific gravity and AVP concentration in the right cortex (non-ischemic area); (2) there were many negative relationships between the specific gravity and AVP levels in the ischemic cortex; (3) intranasal AVP (50 ng or 200 ng), which could pass through the blood-brain barrier to the brain, aggravated the focal cortex edema, whereas intranasal AVP receptor antagonist-D(CH2)5Tyr(ET)DAVP (2 µg) mitigated the cortex edema in the ischemic area after occluding the left carotid artery of Mongolian gerbils; and (4) either intranasal AVP or AVP receptor antagonist did not evoke that edema in the non-ischemic cortex.",intranasal AVP,CHEMICAL,1
23331637,Mouse lines selectively bred for high (HAP) or low (LAP) alcohol preference may be a relevant model of genetic risk for co-morbid alcoholism and PTSD in humans.,alcohol preference,CHEMICAL,1
23331637,Mouse lines selectively bred for high (HAP) or low (LAP) alcohol preference may be a relevant model of genetic risk for co-morbid alcoholism and PTSD in humans.,PTSD,DISEASE,1
23331637,Mouse lines selectively bred for high (HAP) or low (LAP) alcohol preference may be a relevant model of genetic risk for co-morbid alcoholism and PTSD in humans.,alcoholism,DISEASE,1
30579177,These findings suggest that extensive disturbances of phospholipids may be involved in the development of SCZ.,phospholipids,NUTRITION,1
30579177,These findings suggest that extensive disturbances of phospholipids may be involved in the development of SCZ.,SCZ,DISEASE,1
9384820,"The present method of AMPA administration is more suitable for investigating ALS pathogenesis than acute injections, in view of the gradual progression of the disease and the selectivity of lesions produced.",AMPA administration,CHEMICAL,1
9384820,"The present method of AMPA administration is more suitable for investigating ALS pathogenesis than acute injections, in view of the gradual progression of the disease and the selectivity of lesions produced.",ALS pathogenesis,DISEASE,1
33489388,This shift should be considered when hyperthyroidism persists despite reducing or stopping levothyroxine.,hyperthyroidism,DISEASE,1
33489388,This shift should be considered when hyperthyroidism persists despite reducing or stopping levothyroxine.,levothyroxine,CHEMICAL,1
33762687,"TH insufficiency showed a decrease in the expression of parvalbumin (PV) in the cortex and hippocampus of pups at postnatal day (PD) 14, while treatment with thyroxine from PD 0 to PD 14 ameliorated the PV loss.",thyroxine,CHEMICAL,1
33762687,"TH insufficiency showed a decrease in the expression of parvalbumin (PV) in the cortex and hippocampus of pups at postnatal day (PD) 14, while treatment with thyroxine from PD 0 to PD 14 ameliorated the PV loss.",PV loss,DISEASE,1
33762687,"TH insufficiency showed a decrease in the expression of parvalbumin (PV) in the cortex and hippocampus of pups at postnatal day (PD) 14, while treatment with thyroxine from PD 0 to PD 14 ameliorated the PV loss.",PD,DISEASE,1
33762687,"TH insufficiency showed a decrease in the expression of parvalbumin (PV) in the cortex and hippocampus of pups at postnatal day (PD) 14, while treatment with thyroxine from PD 0 to PD 14 ameliorated the PV loss.",TH insufficiency,CHEMICAL,1
33762687,"TH insufficiency showed a decrease in the expression of parvalbumin (PV) in the cortex and hippocampus of pups at postnatal day (PD) 14, while treatment with thyroxine from PD 0 to PD 14 ameliorated the PV loss.",parvalbumin,CHEMICAL,1
31598428,This review highlights the necessity for further research and trials to elucidate the role of naltrexone in human psychogenic drinking behavior.,naltrexone,CHEMICAL,1
31598428,This review highlights the necessity for further research and trials to elucidate the role of naltrexone in human psychogenic drinking behavior.,human psychogenic drinking behavior,DISEASE,1
19647755,"Naltrexone therapy for alcohol abuse may then act, in part, in the NAc by blocking this opioid-triggered cycle of alcohol intake.",alcohol abuse,MENTAL_HEALTH,1
19647755,"Naltrexone therapy for alcohol abuse may then act, in part, in the NAc by blocking this opioid-triggered cycle of alcohol intake.",alcohol intake,CHEMICAL,1
19647755,"Naltrexone therapy for alcohol abuse may then act, in part, in the NAc by blocking this opioid-triggered cycle of alcohol intake.",Naltrexone therapy,CHEMICAL,1
28934988,High prevalence of iron deficiency (ID) and iron deficiency anemia (IDA) has been reported in children with autism spectrum disorder (ASD).,iron deficiency anemia,CHEMICAL,1
28934988,High prevalence of iron deficiency (ID) and iron deficiency anemia (IDA) has been reported in children with autism spectrum disorder (ASD).,autism spectrum disorder,MENTAL_HEALTH,1
28934988,High prevalence of iron deficiency (ID) and iron deficiency anemia (IDA) has been reported in children with autism spectrum disorder (ASD).,ASD,DISEASE,1
28934988,High prevalence of iron deficiency (ID) and iron deficiency anemia (IDA) has been reported in children with autism spectrum disorder (ASD).,iron deficiency,CHEMICAL,1
31860232,"New direct-acting antivirals (DAAs), introduced in late 2013, are effective for treating chronic hepatitis C virus (HCV) infection but may pose substantial financial burden on patients and health insurers.",New direct-acting antivirals,CHEBI,1
31860232,"New direct-acting antivirals (DAAs), introduced in late 2013, are effective for treating chronic hepatitis C virus (HCV) infection but may pose substantial financial burden on patients and health insurers.",chronic virus infection,DISEASE,1
31860232,"New direct-acting antivirals (DAAs), introduced in late 2013, are effective for treating chronic hepatitis C virus (HCV) infection but may pose substantial financial burden on patients and health insurers.",hepatitis C virus,DISEASE,1
31860232,"New direct-acting antivirals (DAAs), introduced in late 2013, are effective for treating chronic hepatitis C virus (HCV) infection but may pose substantial financial burden on patients and health insurers.",New direct-acting antivirals,CHEMICAL,1
9579408,"Our data show that PC12 cell death under high-oxygen conditions is due to apoptosis and that, among the vitamin E homologs, alphaT most effectively prevents hyperoxic apoptosis.",alphaT,CHEMICAL,1
9579408,"Our data show that PC12 cell death under high-oxygen conditions is due to apoptosis and that, among the vitamin E homologs, alphaT most effectively prevents hyperoxic apoptosis.",vitamin E homologs,CHEBI,1
9579408,"Our data show that PC12 cell death under high-oxygen conditions is due to apoptosis and that, among the vitamin E homologs, alphaT most effectively prevents hyperoxic apoptosis.",hyperoxic apoptosis,DISEASE,1
6139118,"In 32 patients with angina of effort, the antianginal effects and action duration of propranolol, atenolol, labetalol and nadolol were compared during the exercise test after a single dose of the drug.",nadolol,CHEMICAL,1
6139118,"In 32 patients with angina of effort, the antianginal effects and action duration of propranolol, atenolol, labetalol and nadolol were compared during the exercise test after a single dose of the drug.",drug,CHEBI,1
6139118,"In 32 patients with angina of effort, the antianginal effects and action duration of propranolol, atenolol, labetalol and nadolol were compared during the exercise test after a single dose of the drug.",propranolol,CHEMICAL,1
6139118,"In 32 patients with angina of effort, the antianginal effects and action duration of propranolol, atenolol, labetalol and nadolol were compared during the exercise test after a single dose of the drug.",atenolol,CHEMICAL,1
6139118,"In 32 patients with angina of effort, the antianginal effects and action duration of propranolol, atenolol, labetalol and nadolol were compared during the exercise test after a single dose of the drug.",labetalol,CHEMICAL,1
27030822,"This localization is ideal if macular xanthophylls are to act as lipid-soluble antioxidants, which is the most accepted mechanism through which lutein and zeaxanthin protect neural tissue against degenerative diseases.",zeaxanthin,CHEBI,1
27030822,"This localization is ideal if macular xanthophylls are to act as lipid-soluble antioxidants, which is the most accepted mechanism through which lutein and zeaxanthin protect neural tissue against degenerative diseases.",degenerative diseases,DISEASE,1
27030822,"This localization is ideal if macular xanthophylls are to act as lipid-soluble antioxidants, which is the most accepted mechanism through which lutein and zeaxanthin protect neural tissue against degenerative diseases.",lutein,CHEBI,1
22512666,"In general, the water solubility of the monomeric Al materials depends on pH and their water solubility and gastrointestinal bioavailability are much greater than that of the hydrated Al silicates.",monomeric Al materials,CHEMICAL,1
22512666,"In general, the water solubility of the monomeric Al materials depends on pH and their water solubility and gastrointestinal bioavailability are much greater than that of the hydrated Al silicates.",gastrointestinal bioavailability,DISEASE,1
